Literature DB >> 14693240

Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma.

Shigehito Wada1, Lihua Yue, Isao Furuta.   

Abstract

We evaluated the prognostic significance of p34cdc2 expression in 50 tongue squamous cell carcinomas (SCC) using immunohistochemical methods. The p34cdc2 protein was expressed in 33 cases of 50 tumor tissues (66.0%), compared with 15 cases of 42 controlled epithelia (35.7%). The expression of p34cdc2 was significantly correlated with the histological grade of tongue carcinoma (P<0.01). In addition, on evaluation of prognosis of tumor, the p34cdc2 protein was overexpressed in recurrent tumors or in those with lymph node metastasis. Statistics showed a significant reduction in the 5-year accumulative survival rate of p34cdc2 positive cases compared with p34cdc2 negative cases (P<0.01). Namely, the p34cdc2 positive patients had worse prognosis. The results suggested that the expression of p34cdc2 suited to the histological grade might reflect the malignant degree of tongue carcinoma biologically. Therefore, the evaluation of p34cdc2 expression was of benefit in elucidating the nature of tumor malignancy and the prognostic prediction of tongue SCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693240     DOI: 10.1016/s1368-8375(03)00146-5

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  3 in total

1.  Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma.

Authors:  Jun-Quan Yang; Hong-Xia Liu; Zhen Liang; Yu-Man Sun; Meng Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  The clinical significance of CDK1 expression in oral squamous cell carcinoma.

Authors:  Xin Chen; Feng-He Zhang; Qiao-Er Chen; Yuan-Yin Wang; Yin-Long Wang; Jia-Cai He; Jian Zhou
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-01-01

3.  Screening and authentication of molecular markers in malignant glioblastoma based on gene expression profiles.

Authors:  Yang-Fan Zou; Ling-Bing Meng; Zhao-Kai He; Chen-Hao Hu; Meng-Jie Shan; Deng-Yuan Wang; Xin Yu
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.